Latus Bio secures $54m for CNS gene therapy development
Latus Bio, a biotechnology company specialising in new gene therapy candidates for central nervous system (CNS) disorders, has announced its launch alongside an initial $54m Series A financing.
Modi Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Modi Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Modi Ventures Today - Breaking & Trending Today
Samsung Life Science Fund invests in US gene therapy firm
Samsung Life Science Fund, an investment fund created by Samsung affiliates, will invest in Latus Bio, a US gene therapy development company, according to Samsung Bioepis on Friday. It is the sixth investment made by the fund between Samsung Biologics, Samsung C&T and Samsung Bioepis, to explore new business opportunities in the biotechnology sector. The exact amount of investment has not been disclosed. Latus Bi...
Source: koreaherald.com
Latus Bio Raises $54M in Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Rubedo Life Sciences Raises $40M in Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Modi Ventures Launches with $32 Million Tech+Bio Fund Targeting Next Frontier of Technologies Disrupting Health and Medicine
/PRNewswire/ -- Modi Ventures, a newly launched venture partnership investing in fund managers and founders building companies shaping the future of humanity,...
Source: prnewswire.com